Israeli biotech Kamada has started producing anti-viper venom serum as a national priority project, financed with NIS 20 million of government money.
http://www.globes.co.il/serveen/globes/docview.asp?did=1000677839&fid=1725
Combating the snake in the grass
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.